FDA and EMA Simultaneously warns of chloroquine

Shell Offshore Inc said that its affiliate, Shell E and P Offshore Services BV, will exercise a contractual right to purchase the Turritella floating, production, storage and offloading (FPSO) vessel from SBM Offshore.
The vessel is contracted for the Stones deep-water development in the Gulf of Mexico, which began production last year. Shell and SBM will work over the next several months to achieve a safe, smooth transition of the vessel operations.
Transitioning the ownership and operations of the vessel to Shell affiliates allows the company to pursue additional efficiencies and achieve cost improvements to deliver shareholder value at Stones with a continued commitment to operational excellence and safety. The Stones development is the world’s deepest offshore oil and gas project and is scheduled to deliver approximately 50,000-barrels of oil equivalent per day (boe/d) by the end of this year.
The Turritella FPSO has a daily production capacity of approximately 60,000 barrels of oil and 15 million cubic feet of natural gas and fits well within Shell’s global, deep-water portfolio, which includes operations in the Gulf of Mexico, Brazil, Nigeria, and Malaysia. Competitive, deep-water oil resources are a growth priority for Shell with global production expected to reach more than 900-thousand boe/d by the early 2020s.
Currently, Shell has three additional Gulf of Mexico deepwater projects under construction – Appomattox, Kaikias, and Coulomb Phase 2 – as well as options for additional subsea tiebacks and Vito, a potential, new hub in the region.
2026-08-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Did Hydroxychloroquine Cause Thousands of Deaths During the COVID-19 Pandemic?
-
EMA:The efficacy of chloroquine against the COVID-19 has not been confirmed
-
Quality or quantity? The quality of hydroxychloroquine donated by Bayer
-
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
-
To increase supply, FDA issued special guidelines for chloroquine drugs
-
After 'initial shock,' generics supply chain likely to weather COVID-19 blows
-
Chinese APIs flowing but India ban hinders U.S. approval of hydroxychloroquine
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales
Recommend Reading
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Bearish Factors Suppress Hydrogen Peroxide Prices in China
-
Sodium Metabisulfite Prices Decline This Week in China (9.15-9.19)
-
Strong Supply and Weak Demand Continues, PP Fluctuates and Falls in November
-
This week, the market price of isopropanol in China slightly decreased (9.15-9.19)
-
In November, the market price of anhydrous hydrogen fluoride in China showed a downward trend